Sector: Healthcare | Industry: Medical Equipment, Supplies & Distribution |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 9120 LOCKWOOD BLVD MECHANICSVILLE VA 23116 |
Tel: | N/A |
Website: | https://www.owens-minor.com |
IR: | See website |
Key People | ||
Edward A. Pesicka President, Chief Executive Officer, Director | Alexander J. Bruni Chief Financial Officer, Executive Vice President | Heath H. Galloway Executive Vice President, General Counsel, Corporate Secretary |
Perry Bernocchi Executive Vice President, Chief Executive Officer of Patient Direct Segment | Andrew G. Long Executive Vice President, Chief Executive Officer of Products and Healthcare Services | Daniel J. Starck Executive Vice President - Business Excellence |
Michael Wayne Lowry Senior Vice President, Corporate Controller, Chief Accounting Officer | Jonathan A. Leon Senior Vice President, Corporate Treasurer |
Business Overview |
Owens & Minor, Inc. is a global healthcare solutions company providing essential products and services that support care from the hospital to the home. The Company operates through two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a comprehensive portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products purchased from manufacturers and its own proprietary products. Its service offerings to healthcare providers include supplier management, analytics, inventory management, and clinical supply management. It also offers a variety of programs providing outsourced logistics and marketing solutions to its suppliers as well. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies and a provider of integrated home healthcare equipment and related services. |
Financial Overview |
For the fiscal year ended 31 December 2023, Owens & Minor, Inc. revenues increased 4% to $10.33B. Net loss totaled $41.3M vs. income of $22.4M. Revenues reflect Patient Direct segment increase of 24% to $2.55B, United States segment increase of 6% to $10.06B. Net loss reflects Products & Healthcare Services segment income decrease of 67% to $57.8M, Acquisition related and exit and realignment charges segment loss increase of 84% to $101M. |
Employees: | 13,700 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $3,752M as of Dec 31, 2023 |
Annual revenue (TTM): | $10,334M as of Dec 31, 2023 |
EBITDA (TTM): | $609.55M as of Dec 31, 2023 |
Net annual income (TTM): | -$41.30M as of Dec 31, 2023 |
Free cash flow (TTM): | $532.82M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $1,857M as of Dec 31, 2023 |
Shares outstanding: | 76,598,351 as of Mar 14, 2024 |
Index Membership: | S&P 600 Small Cap |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |